These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 7788877

  • 1. Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle.
    Hussain T, Mustafa SJ.
    Circ Res; 1995 Jul; 77(1):194-8. PubMed ID: 7788877
    [Abstract] [Full Text] [Related]

  • 2. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P, Nordstedt C, Fredholm BB.
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [Abstract] [Full Text] [Related]

  • 3. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM, Alexander SP, Hill SJ.
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [Abstract] [Full Text] [Related]

  • 4. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP, Curtis AR, Kendall DA, Hill SJ.
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [Abstract] [Full Text] [Related]

  • 5. Pronounced direct inhibitory action mediated by adenosine A1 receptor and pertussis toxin-sensitive G protein on the ferret ventricular contraction.
    Endoh M, Takanashi M, Norota I, Kawabata Y, Asano T.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):282-9. PubMed ID: 8232606
    [Abstract] [Full Text] [Related]

  • 6. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
    Liang BT.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):775-84. PubMed ID: 2732946
    [Abstract] [Full Text] [Related]

  • 8. Modulation of protein kinase C by adenosine: involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein system.
    Marala RB, Mustafa SJ.
    Mol Cell Biochem; 1995 Jun; 149-150():51-8. PubMed ID: 8569749
    [Abstract] [Full Text] [Related]

  • 9. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.
    Peachey JA, Hourani SM, Kitchen I.
    Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280
    [Abstract] [Full Text] [Related]

  • 10. Characterization of 5'-N-ethylcarboxamido[3H]adenosine binding to pig aorta smooth muscle membranes.
    Diocee BK, Souness JE.
    Biochem Pharmacol; 1987 Nov 01; 36(21):3621-7. PubMed ID: 2823828
    [Abstract] [Full Text] [Related]

  • 11. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T, Itahashi Y, Nomura Y.
    J Neurochem; 1990 Nov 01; 55(5):1631-8. PubMed ID: 2145396
    [Abstract] [Full Text] [Related]

  • 12. Adenosine receptor-mediated inhibition of cardiac adenylyl cyclase activity may involve multiple receptor subtypes.
    Ma H, Yu HJ, Green RD.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan 01; 349(1):81-6. PubMed ID: 8139704
    [Abstract] [Full Text] [Related]

  • 13. Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium.
    Abebe W, Makujina SR, Mustafa SJ.
    Am J Physiol; 1994 May 01; 266(5 Pt 2):H2018-25. PubMed ID: 8203600
    [Abstract] [Full Text] [Related]

  • 14. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
    Smith AD, Cheek DJ, Buxton IL, Westfall DP.
    Clin Exp Pharmacol Physiol; 1997 Jul 01; 24(7):492-7. PubMed ID: 9248666
    [Abstract] [Full Text] [Related]

  • 15. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA, Constantino MD, Ribeiro JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 01; 359(4):295-302. PubMed ID: 10344528
    [Abstract] [Full Text] [Related]

  • 16. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun 01; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 17. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.
    Br J Pharmacol; 1997 Nov 01; 122(6):1202-8. PubMed ID: 9401787
    [Abstract] [Full Text] [Related]

  • 18. Adenosine analogues prevent phorbol ester-induced PKC depletion in porcine coronary artery via A1 receptor.
    Marala RB, Mustafa SJ.
    Am J Physiol; 1995 Jan 01; 268(1 Pt 2):H271-7. PubMed ID: 7840272
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes.
    Stein B, Schmitz W, Scholz H, Seeland C.
    J Mol Cell Cardiol; 1994 Mar 01; 26(3):403-14. PubMed ID: 8028023
    [Abstract] [Full Text] [Related]

  • 20. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H, Mori A, Ichimura M, Shindou T, Yanagawa K, Shimada J, Kase H.
    Mol Pharmacol; 1994 Nov 01; 46(5):817-22. PubMed ID: 7969067
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.